Visioneering Technologies Inc. is an innovative company headquartered in Alpharetta, Georgia, dedicated to redefining vision with a strong focus on addressing eye care issues. Founded in 2008, the company aims to enhance practitioner and patient experiences through its portfolio of technologies, including the NaturalVue® (etafilcon A) Multifocal One Day Contact Lenses. With a total of 14 issued patents worldwide and 8 pending patents, VTI is primarily focused on providing treatment for presbyopia in the underdeveloped on-eye/in-eye categories, as well as myopia correction in children. The company brings together industry veterans from various backgrounds including clinical, marketing, engineering, manufacturing, and regulatory sectors to design and market new solutions for presbyopia, myopia, and astigmatism. VTI operates within the Manufacturing industry and is based in the United States. Currently, there is no public information available regarding the last investment or the investors involved.
There is no investment information
No recent news or press coverage available for Visioneering Technologies Inc..